Portfolio company
Abalone Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
LabGenius
This biopharmaceutical company develops therapeutic antibodies using an automated protein engineering platform for pharmaceutical and biotechnology partners.
Antiverse
This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.
Absci
This biopharmaceutical company uses generative artificial intelligence to design and develop biologic medicines for pharmaceutical partners and clinical patients.
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
BigHat Biosciences
BigHat Biosciences develops machine learning-designed antibody therapeutics for pharmaceutical partners and patients in oncology and immunology.
Metaphore Biotechnologies
This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.
AbCellera
This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.
